| 臺大學術典藏 |
2021-01-29T03:17:27Z |
Association between Schizophrenia and Urinary Calculi: A Population-Based Case-Control Study
|
SHIH-PING LIU; Lin C.-C.; Lin H.-C.; Chen Y.-H.; Yu H.-J. |
| 臺大學術典藏 |
2021-01-29T03:17:26Z |
Bladder Pain Syndrome/Interstitial Cystitis Is Associated with Hyperthyroidism
|
Chung S.-D.; SHIH-PING LIU; Lin C.-C.; Li H.-C.; Lin H.-C. |
| 臺大學術典藏 |
2021-01-29T03:17:23Z |
Obstructive sleep apnea increases the risk of bladder pain syndrome/interstitial cystitis: A population-based matched-cohort study
|
Chung S.-D.;Lin C.-C.;Shih-Ping Liu;Lin H.-C.; Chung S.-D.; Lin C.-C.; SHIH-PING LIU; Lin H.-C. |
| 臺大學術典藏 |
2021-01-29T03:17:21Z |
Increased healthcare service utilizations for patients with dementia: A population-based study
|
Chung S.-D.;Shih-Ping Liu;Sheu J.-J.;Lin C.-C.;Lin H.-C.;Chen C.-H.; Chung S.-D.; SHIH-PING LIU; Sheu J.-J.; Lin C.-C.; Lin H.-C.; Chen C.-H. |
| 臺大學術典藏 |
2021-01-28T03:15:18Z |
A double-blind, randomized, placebo-controlled, parallel study to evaluate the efficacy and safety of imidafenacin in patients with overactive bladder in Taiwan
|
Chuang Y.-C.; Lin C.-C.; PO-MING CHOW; Lien C.-S.; Tsui K.-H.; Chou C.-L.; Lee H.-Y.; Meng E.; Kuo H.-C. |
| 臺大學術典藏 |
2021-01-28T02:03:59Z |
Changing trends of prostate cancer in Asia
|
Pu Y.-S.;Chiang H.-S.;Lin C.-C.;Huang C.-Y.;Kuo-How Huang;Chen J.; Pu Y.-S.; Chiang H.-S.; Lin C.-C.; Huang C.-Y.; KUO-HOW HUANG; Chen J. |
| 臺大學術典藏 |
2021-01-28T02:03:54Z |
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study
|
Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; KUO-HOW HUANG; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-01-28T02:03:54Z |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Tsai Y.-C.; KUO-HOW HUANG; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-01-28T02:03:53Z |
Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial
|
Lin C.-C.;Hsu C.-H.;Hour T.-C.;Cheng A.-L.;Huang C.-Y.;Kuo-How Huang;Chen J.;Pu Y.-S.; Lin C.-C.; Hsu C.-H.; Hour T.-C.; Cheng A.-L.; Huang C.-Y.; KUO-HOW HUANG; Chen J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-01-28T02:03:44Z |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
Lin C.-C.; Hsu C.-H.; Cheng J.C.; Huang C.-Y.; Tsai Y.-C.; Hsu F.-M.; KUO-HOW HUANG; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-01-28T01:06:52Z |
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
|
Hsu C.-H.;Cheng A.-L.;Hsu C.;Yang C.-H.;Lu Y.-S.;Lin C.-C.;Bu C.-F.;Kun-Huei Yeh; Hsu C.-H.; Cheng A.-L.; Hsu C.; Yang C.-H.; Lu Y.-S.; Lin C.-C.; Bu C.-F.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:46Z |
Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer
|
Lin C.-C.;Hsu C.-H.;Cheng J.C.;Wang H.-P.;Lee J.-M.;Kun-Huei Yeh;Yang C.-H.;Lin J.-T.;Cheng A.-L.;Lee Y.-C.; Lin C.-C.; Hsu C.-H.; Cheng J.C.; Wang H.-P.; Lee J.-M.; KUN-HUEI YEH; Yang C.-H.; Lin J.-T.; Cheng A.-L.; Lee Y.-C. |
| 臺大學術典藏 |
2021-01-28T01:06:45Z |
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
|
Lin C.-C.;Kun-Huei Yeh;Yang C.-H.;Hsu C.;Tsai Y.-C.;Hsu W.-L.;Cheng A.-L.;Hsu C.-H.; Lin C.-C.; KUN-HUEI YEH; Yang C.-H.; Hsu C.; Tsai Y.-C.; Hsu W.-L.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:45Z |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
|
Lin C.-C.;Cheng A.-L.;Hsu C.-H.;Lu Y.-S.;Hsu C.;Kun-Huei Yeh;Wu C.-Y.;Huang C.-S.;Yang C.-H.; Lin C.-C.; Cheng A.-L.; Hsu C.-H.; Lu Y.-S.; Hsu C.; KUN-HUEI YEH; Wu C.-Y.; Huang C.-S.; Yang C.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:36Z |
Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy
|
Chen W.-W.;Lin C.-C.;Huang T.-C.;Cheng A.-L.;Kun-Huei Yeh;Hsu C.-H.; Chen W.-W.; Lin C.-C.; Huang T.-C.; Cheng A.-L.; KUN-HUEI YEH; Hsu C.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:32Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C.; Su W.-C.; Yen C.-J.; Hsu C.-H.; Su W.-P.; KUN-HUEI YEH; Lu Y.-S.; Cheng A.-L.; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:28Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Guo J.-C.;Huang T.-C.;Lin C.-C.;Hsieh M.-S.;Chang C.-H.;Huang P.-M.;Lee J.-M.;Hsu F.-M.;Cheng J.C.-H.;Wang H.-P.;Kun-Huei Yeh;Cheng A.-L.;Hsu C.-H.; Guo J.-C.; Huang T.-C.; Lin C.-C.; Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; Wang H.-P.; KUN-HUEI YEH; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:20Z |
Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy
|
Guo J.-C.;Lin C.-C.;Huang T.-C.;Huang P.-M.;Kuo H.-Y.;Chang C.-H.;Wang C.-C.;Cheng J.C.-H.;Kun-Huei Yeh;Hsu C.-H.;Lee J.-M.; Guo J.-C.; Lin C.-C.; Huang T.-C.; Huang P.-M.; Kuo H.-Y.; Chang C.-H.; Wang C.-C.; Cheng J.C.-H.; KUN-HUEI YEH; Hsu C.-H.; Lee J.-M. |
| 臺大學術典藏 |
2021-01-28T01:06:19Z |
A Phase i study of S-1-based concurrent chemoradiotherapy followed by gemcitabine and S-1 in metastatic pancreatic adenocarcinoma
|
Yang S.-H.;Shao Y.-Y.;Lin C.-C.;Kuo S.-H.;Cheng A.-L.;Kun-Huei Yeh; Yang S.-H.; Shao Y.-Y.; Lin C.-C.; Kuo S.-H.; Cheng A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:17Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Huang T.-C.;Lin C.-C.;Wu Y.-C.;Chia-Hsien Cheng J.;Lee J.-M.;Wang H.-P.;Huang P.-M.;Hsu F.-M.;Kun-Huei Yeh;Cheng A.-L.;Tzen K.-Y.;Hsu C.-H.; Huang T.-C.; Lin C.-C.; Wu Y.-C.; Chia-Hsien Cheng J.; Lee J.-M.; Wang H.-P.; Huang P.-M.; Hsu F.-M.; KUN-HUEI YEH; Cheng A.-L.; Tzen K.-Y.; Hsu C.-H. |
| 臺大學術典藏 |
2021-01-27T06:53:41Z |
Assessing seasonal and interannual water storage variations in Taiwan using geodetic and hydrological data
|
Hsu, Y.-J.;Fu, Y.;Bürgmann, R.;Hsu, S.-Y.;Lin, C.-C.;Tang, C.-H.;Wu, Y.-M.; Hsu, Y.-J.; Fu, Y.; Bürgmann, R.; Hsu, S.-Y.; Lin, C.-C.; Tang, C.-H.; Wu, Y.-M.; YIH-MIN WU |
| 臺大學術典藏 |
2021-01-27T06:51:43Z |
New biscembranoids sardigitolides A-D and known cembranoid-related compounds from Sarcophyton digitatum: Isolation, structure elucidation, and bioactivities
|
Huang, T.-Y.;Huang, C.-Y.;Chao, C.-H.;Lin, C.-C.;Dai, C.-F.;Su, J.-H.;Sung, P.-J.;Wu, S.-H.;Sheu, J.-H.; Huang, T.-Y.; Huang, C.-Y.; Chao, C.-H.; Lin, C.-C.; Dai, C.-F.; Su, J.-H.; Sung, P.-J.; Wu, S.-H.; Sheu, J.-H.; CHANG-FENG DAI |
| 臺大學術典藏 |
2021-01-27T03:23:42Z |
Assessing seasonal and interannual water storage variations in Taiwan using geodetic and hydrological data
|
Hsu, Y.-J.;Fu, Y.;Bürgmann, R.;Hsu, S.-Y.;Lin, C.-C.;Tang, C.-H.;Wu, Y.-M.; Hsu, Y.-J.; Fu, Y.; Bürgmann, R.; Hsu, S.-Y.; Lin, C.-C.; Tang, C.-H.; Wu, Y.-M.; YIH-MIN WU |
| 臺大學術典藏 |
2021-01-27T03:21:44Z |
New biscembranoids sardigitolides A-D and known cembranoid-related compounds from Sarcophyton digitatum: Isolation, structure elucidation, and bioactivities
|
Huang, T.-Y.;Huang, C.-Y.;Chao, C.-H.;Lin, C.-C.;Dai, C.-F.;Su, J.-H.;Sung, P.-J.;Wu, S.-H.;Sheu, J.-H.; Huang, T.-Y.; Huang, C.-Y.; Chao, C.-H.; Lin, C.-C.; Dai, C.-F.; Su, J.-H.; Sung, P.-J.; Wu, S.-H.; Sheu, J.-H.; CHANG-FENG DAI |
| 臺大學術典藏 |
2021-01-26T02:27:49Z |
Altered prostate epithelial development and IGF-1 signal in mice lacking the androgen receptor in stromal smooth muscle cells
|
Yu S. ;Zhang C. ;Lin C.-C. ;Niu Y. ;Lai K.-P. ;Hong-Chiang Chang ;Yeh S.-D. ;Chang C. ;Yeh S.; Yu S.; Zhang C.; Lin C.-C.; Niu Y.; Lai K.-P.; HONG-CHIANG CHANG; Yeh S.-D.; Chang C.; Yeh S. |
